← Back to Search

Device

Eye4 for Low Vision (DRTARES Trial)

N/A
Waitlist Available
Led By Mitul Mehta, MD
Research Sponsored by Eyedaptic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

DRTARES Trial Summary

This trial will test whether an augmented reality visual aid can help improve the vision of people with diabetic retinopathy.

Eligible Conditions
  • Low Vision
  • Diabetic Retinopathy

DRTARES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual acuity at distance
Secondary outcome measures
Contrast sensitivity
Visual acuity at near

DRTARES Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Eye4Experimental Treatment1 Intervention
This is the arm with the Eyedaptic Device
Group II: BaselinePlacebo Group1 Intervention
This is the placebo arm with the best correction the subject has
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Eye4
2022
N/A
~20

Find a Location

Who is running the clinical trial?

EyedapticLead Sponsor
Mitul Mehta, MDPrincipal InvestigatorEyedaptic
1 Previous Clinical Trials
30 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025